nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—muscle cancer—head and neck cancer	0.139	0.284	CtDrD
Etoposide—germ cell cancer—head and neck cancer	0.125	0.255	CtDrD
Etoposide—PTGS2—head and neck cancer	0.123	1	CbGaD
Etoposide—peripheral nervous system neoplasm—head and neck cancer	0.115	0.235	CtDrD
Etoposide—sarcoma—head and neck cancer	0.111	0.226	CtDrD
Etoposide—ABCC6—Vinblastine—head and neck cancer	0.0689	0.253	CbGbCtD
Etoposide—ABCC10—Docetaxel—head and neck cancer	0.0434	0.159	CbGbCtD
Etoposide—ABCC3—Fluorouracil—head and neck cancer	0.0357	0.131	CbGbCtD
Etoposide—ABCC1—Vinblastine—head and neck cancer	0.0203	0.0745	CbGbCtD
Etoposide—ABCC1—Docetaxel—head and neck cancer	0.0168	0.0614	CbGbCtD
Etoposide—ABCC2—Vinblastine—head and neck cancer	0.0151	0.0551	CbGbCtD
Etoposide—ABCG2—Fluorouracil—head and neck cancer	0.0147	0.0538	CbGbCtD
Etoposide—ABCC2—Docetaxel—head and neck cancer	0.0124	0.0455	CbGbCtD
Etoposide—ABCG2—Docetaxel—head and neck cancer	0.0112	0.0411	CbGbCtD
Etoposide—CYP2C8—Fluorouracil—head and neck cancer	0.00782	0.0287	CbGbCtD
Etoposide—CYP3A5—Docetaxel—head and neck cancer	0.00621	0.0228	CbGbCtD
Etoposide—CYP1A2—Fluorouracil—head and neck cancer	0.00606	0.0222	CbGbCtD
Etoposide—ABCB1—Vinblastine—head and neck cancer	0.00491	0.018	CbGbCtD
Etoposide—ABCB1—Docetaxel—head and neck cancer	0.00404	0.0148	CbGbCtD
Etoposide—CYP3A4—Vinblastine—head and neck cancer	0.00294	0.0108	CbGbCtD
Etoposide—CYP3A4—Docetaxel—head and neck cancer	0.00242	0.00888	CbGbCtD
Etoposide—Cardiotoxicity—Fluorouracil—head and neck cancer	0.00129	0.0188	CcSEcCtD
Etoposide—Recall phenomenon—Docetaxel—head and neck cancer	0.00126	0.0184	CcSEcCtD
Etoposide—Neutropenic sepsis—Docetaxel—head and neck cancer	0.00126	0.0184	CcSEcCtD
Etoposide—Skin necrosis—Hydroxyurea—head and neck cancer	0.00121	0.0176	CcSEcCtD
Etoposide—Septic shock—Fluorouracil—head and neck cancer	0.00101	0.0146	CcSEcCtD
Etoposide—Myelosuppression—Vinblastine—head and neck cancer	0.000988	0.0144	CcSEcCtD
Etoposide—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.00096	0.014	CcSEcCtD
Etoposide—Cardiotoxicity—Docetaxel—head and neck cancer	0.000931	0.0135	CcSEcCtD
Etoposide—Myelosuppression—Hydroxyurea—head and neck cancer	0.000901	0.0131	CcSEcCtD
Etoposide—GSTT1—mouth—head and neck cancer	0.000872	0.0533	CbGeAlD
Etoposide—TOP2B—hair follicle—head and neck cancer	0.000818	0.05	CbGeAlD
Etoposide—Acute leukaemia—Docetaxel—head and neck cancer	0.000768	0.0112	CcSEcCtD
Etoposide—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.000763	0.0111	CcSEcCtD
Etoposide—GSTT1—neck—head and neck cancer	0.000745	0.0456	CbGeAlD
Etoposide—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000702	0.0102	CcSEcCtD
Etoposide—Myelosuppression—Fluorouracil—head and neck cancer	0.000648	0.00943	CcSEcCtD
Etoposide—Neurotoxicity—Docetaxel—head and neck cancer	0.000566	0.00823	CcSEcCtD
Etoposide—Numbness—Vinblastine—head and neck cancer	0.000559	0.00812	CcSEcCtD
Etoposide—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.000547	0.00795	CcSEcCtD
Etoposide—GSTP1—exocrine gland—head and neck cancer	0.000538	0.0329	CbGeAlD
Etoposide—Sensory loss—Vinblastine—head and neck cancer	0.000535	0.00777	CcSEcCtD
Etoposide—Extravasation—Vinblastine—head and neck cancer	0.000531	0.00772	CcSEcCtD
Etoposide—GSTP1—hair follicle—head and neck cancer	0.000513	0.0313	CbGeAlD
Etoposide—Cellulitis—Vinblastine—head and neck cancer	0.000509	0.0074	CcSEcCtD
Etoposide—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000505	0.00735	CcSEcCtD
Etoposide—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.000499	0.00725	CcSEcCtD
Etoposide—Ascites—Docetaxel—head and neck cancer	0.000483	0.00702	CcSEcCtD
Etoposide—Nail disorder—Fluorouracil—head and neck cancer	0.000469	0.00681	CcSEcCtD
Etoposide—Myelosuppression—Docetaxel—head and neck cancer	0.000468	0.0068	CcSEcCtD
Etoposide—PTGS2—cartilage tissue—head and neck cancer	0.000462	0.0283	CbGeAlD
Etoposide—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.000455	0.00662	CcSEcCtD
Etoposide—Interstitial pneumonia—Docetaxel—head and neck cancer	0.000454	0.0066	CcSEcCtD
Etoposide—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.000451	0.317	CbGdCrCtD
Etoposide—TOP2B—parotid gland—head and neck cancer	0.000447	0.0273	CbGeAlD
Etoposide—Ulcer—Hydroxyurea—head and neck cancer	0.000446	0.00649	CcSEcCtD
Etoposide—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.000442	0.312	CbGdCrCtD
Etoposide—ABCC6—connective tissue—head and neck cancer	0.000434	0.0265	CbGeAlD
Etoposide—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00043	0.00625	CcSEcCtD
Etoposide—TOP2B—saliva-secreting gland—head and neck cancer	0.000428	0.0262	CbGeAlD
Etoposide—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000403	0.00586	CcSEcCtD
Etoposide—GSTP1—mouth—head and neck cancer	0.000402	0.0246	CbGeAlD
Etoposide—Mucosal inflammation—Docetaxel—head and neck cancer	0.000396	0.00576	CcSEcCtD
Etoposide—TOP2B—connective tissue—head and neck cancer	0.000393	0.0241	CbGeAlD
Etoposide—GSTT1—lymphoid tissue—head and neck cancer	0.000391	0.0239	CbGeAlD
Etoposide—Phlebitis—Vinblastine—head and neck cancer	0.00039	0.00567	CcSEcCtD
Etoposide—Necrosis—Fluorouracil—head and neck cancer	0.000387	0.00563	CcSEcCtD
Etoposide—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.000384	0.00558	CcSEcCtD
Etoposide—Tingling sensation—Fluorouracil—head and neck cancer	0.000378	0.0055	CcSEcCtD
Etoposide—Numbness—Fluorouracil—head and neck cancer	0.000367	0.00533	CcSEcCtD
Etoposide—Febrile neutropenia—Docetaxel—head and neck cancer	0.000365	0.0053	CcSEcCtD
Etoposide—ABCC1—hair follicle—head and neck cancer	0.000362	0.0221	CbGeAlD
Etoposide—GSTT1—thyroid gland—head and neck cancer	0.000355	0.0217	CbGeAlD
Etoposide—Sensory loss—Fluorouracil—head and neck cancer	0.000351	0.0051	CcSEcCtD
Etoposide—Extravasation—Fluorouracil—head and neck cancer	0.000348	0.00507	CcSEcCtD
Etoposide—GSTP1—neck—head and neck cancer	0.000344	0.021	CbGeAlD
Etoposide—Nail disorder—Docetaxel—head and neck cancer	0.000338	0.00492	CcSEcCtD
Etoposide—Cellulitis—Fluorouracil—head and neck cancer	0.000334	0.00486	CcSEcCtD
Etoposide—TOP2B—trachea—head and neck cancer	0.00033	0.0202	CbGeAlD
Etoposide—Ulcer—Fluorouracil—head and neck cancer	0.000321	0.00467	CcSEcCtD
Etoposide—GSTT1—head—head and neck cancer	0.000315	0.0192	CbGeAlD
Etoposide—Inflammation—Fluorouracil—head and neck cancer	0.000313	0.00456	CcSEcCtD
Etoposide—Interstitial lung disease—Docetaxel—head and neck cancer	0.00031	0.00451	CcSEcCtD
Etoposide—ABCC6—thyroid gland—head and neck cancer	0.000288	0.0176	CbGeAlD
Etoposide—TOP2B—lymphoid tissue—head and neck cancer	0.000288	0.0176	CbGeAlD
Etoposide—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.000284	0.2	CbGdCrCtD
Etoposide—Hepatotoxicity—Docetaxel—head and neck cancer	0.000284	0.00413	CcSEcCtD
Etoposide—GSTP1—parotid gland—head and neck cancer	0.00028	0.0171	CbGeAlD
Etoposide—ABCC10—parotid gland—head and neck cancer	0.00028	0.0171	CbGeAlD
Etoposide—Necrosis—Docetaxel—head and neck cancer	0.00028	0.00406	CcSEcCtD
Etoposide—Oesophagitis—Fluorouracil—head and neck cancer	0.000278	0.00404	CcSEcCtD
Etoposide—Rash maculo-papular—Fluorouracil—head and neck cancer	0.000276	0.00402	CcSEcCtD
Etoposide—Pancytopenia—Vinblastine—head and neck cancer	0.000276	0.00401	CcSEcCtD
Etoposide—Rigors—Docetaxel—head and neck cancer	0.000269	0.00391	CcSEcCtD
Etoposide—GSTP1—saliva-secreting gland—head and neck cancer	0.000268	0.0164	CbGeAlD
Etoposide—ABCC10—saliva-secreting gland—head and neck cancer	0.000268	0.0164	CbGeAlD
Etoposide—Sepsis—Fluorouracil—head and neck cancer	0.000264	0.00384	CcSEcCtD
Etoposide—TOP2B—thyroid gland—head and neck cancer	0.000261	0.016	CbGeAlD
Etoposide—ABCC6—head—head and neck cancer	0.000255	0.0156	CbGeAlD
Etoposide—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000255	0.00371	CcSEcCtD
Etoposide—Myocardial infarction—Vinblastine—head and neck cancer	0.000254	0.00369	CcSEcCtD
Etoposide—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000254	0.00369	CcSEcCtD
Etoposide—Pancytopenia—Hydroxyurea—head and neck cancer	0.000252	0.00366	CcSEcCtD
Etoposide—Extravasation—Docetaxel—head and neck cancer	0.000251	0.00366	CcSEcCtD
Etoposide—Swelling—Fluorouracil—head and neck cancer	0.00025	0.00364	CcSEcCtD
Etoposide—Chest discomfort—Docetaxel—head and neck cancer	0.000248	0.00361	CcSEcCtD
Etoposide—Neutropenia—Hydroxyurea—head and neck cancer	0.000248	0.0036	CcSEcCtD
Etoposide—GSTP1—connective tissue—head and neck cancer	0.000246	0.0151	CbGeAlD
Etoposide—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.000243	0.171	CbGdCrCtD
Etoposide—Agranulocytosis—Vinblastine—head and neck cancer	0.000242	0.00351	CcSEcCtD
Etoposide—Infestation NOS—Hydroxyurea—head and neck cancer	0.000236	0.00343	CcSEcCtD
Etoposide—Infestation—Hydroxyurea—head and neck cancer	0.000236	0.00343	CcSEcCtD
Etoposide—GSTP1—epithelium—head and neck cancer	0.000234	0.0143	CbGeAlD
Etoposide—TOP2B—head—head and neck cancer	0.000232	0.0142	CbGeAlD
Etoposide—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000232	0.00337	CcSEcCtD
Etoposide—Hypoaesthesia—Vinblastine—head and neck cancer	0.000231	0.00336	CcSEcCtD
Etoposide—Stomatitis—Hydroxyurea—head and neck cancer	0.00023	0.00335	CcSEcCtD
Etoposide—Inflammation—Docetaxel—head and neck cancer	0.000226	0.00329	CcSEcCtD
Etoposide—Cardiac failure—Fluorouracil—head and neck cancer	0.000226	0.00329	CcSEcCtD
Etoposide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000223	0.00325	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000219	0.00319	CcSEcCtD
Etoposide—Cardiac arrest—Fluorouracil—head and neck cancer	0.00021	0.00305	CcSEcCtD
Etoposide—Skin exfoliation—Docetaxel—head and neck cancer	0.000209	0.00305	CcSEcCtD
Etoposide—Candida infection—Docetaxel—head and neck cancer	0.000209	0.00305	CcSEcCtD
Etoposide—GSTP1—trachea—head and neck cancer	0.000207	0.0126	CbGeAlD
Etoposide—ABCC10—trachea—head and neck cancer	0.000207	0.0126	CbGeAlD
Etoposide—Neuropathy—Docetaxel—head and neck cancer	0.000206	0.003	CcSEcCtD
Etoposide—Alopecia—Vinblastine—head and neck cancer	0.000205	0.00299	CcSEcCtD
Etoposide—Oesophagitis—Docetaxel—head and neck cancer	0.0002	0.00291	CcSEcCtD
Etoposide—ABCC1—parotid gland—head and neck cancer	0.000198	0.0121	CbGeAlD
Etoposide—Angiopathy—Hydroxyurea—head and neck cancer	0.000192	0.0028	CcSEcCtD
Etoposide—TOP2A—thyroid gland—head and neck cancer	0.000192	0.0117	CbGeAlD
Etoposide—Dysphagia—Fluorouracil—head and neck cancer	0.000191	0.00277	CcSEcCtD
Etoposide—Sepsis—Docetaxel—head and neck cancer	0.00019	0.00277	CcSEcCtD
Etoposide—Chills—Hydroxyurea—head and neck cancer	0.00019	0.00277	CcSEcCtD
Etoposide—Ill-defined disorder—Vinblastine—head and neck cancer	0.000188	0.00273	CcSEcCtD
Etoposide—PTGS2—mouth—head and neck cancer	0.000188	0.0115	CbGeAlD
Etoposide—Alopecia—Hydroxyurea—head and neck cancer	0.000187	0.00272	CcSEcCtD
Etoposide—Anaemia—Vinblastine—head and neck cancer	0.000187	0.00272	CcSEcCtD
Etoposide—Phlebitis—Docetaxel—head and neck cancer	0.000185	0.00269	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000183	0.00266	CcSEcCtD
Etoposide—Malaise—Vinblastine—head and neck cancer	0.000183	0.00265	CcSEcCtD
Etoposide—Vertigo—Vinblastine—head and neck cancer	0.000182	0.00264	CcSEcCtD
Etoposide—Leukopenia—Vinblastine—head and neck cancer	0.000181	0.00263	CcSEcCtD
Etoposide—Pancytopenia—Fluorouracil—head and neck cancer	0.000181	0.00263	CcSEcCtD
Etoposide—Swelling—Docetaxel—head and neck cancer	0.000181	0.00262	CcSEcCtD
Etoposide—GSTP1—lymphoid tissue—head and neck cancer	0.00018	0.011	CbGeAlD
Etoposide—ABCC10—lymphoid tissue—head and neck cancer	0.00018	0.011	CbGeAlD
Etoposide—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000176	0.00255	CcSEcCtD
Etoposide—Convulsion—Vinblastine—head and neck cancer	0.000175	0.00255	CcSEcCtD
Etoposide—Hypertension—Vinblastine—head and neck cancer	0.000175	0.00254	CcSEcCtD
Etoposide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000171	0.00249	CcSEcCtD
Etoposide—Pneumonia—Fluorouracil—head and neck cancer	0.000171	0.00249	CcSEcCtD
Etoposide—Anaemia—Hydroxyurea—head and neck cancer	0.000171	0.00248	CcSEcCtD
Etoposide—Discomfort—Vinblastine—head and neck cancer	0.00017	0.00248	CcSEcCtD
Etoposide—Infestation NOS—Fluorouracil—head and neck cancer	0.00017	0.00247	CcSEcCtD
Etoposide—Infestation—Fluorouracil—head and neck cancer	0.00017	0.00247	CcSEcCtD
Etoposide—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000168	0.00244	CcSEcCtD
Etoposide—Myocardial infarction—Fluorouracil—head and neck cancer	0.000167	0.00242	CcSEcCtD
Etoposide—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000167	0.00242	CcSEcCtD
Etoposide—Malaise—Hydroxyurea—head and neck cancer	0.000166	0.00242	CcSEcCtD
Etoposide—Stomatitis—Fluorouracil—head and neck cancer	0.000166	0.00241	CcSEcCtD
Etoposide—Leukopenia—Hydroxyurea—head and neck cancer	0.000165	0.0024	CcSEcCtD
Etoposide—ABCC3—thyroid gland—head and neck cancer	0.000164	0.01	CbGeAlD
Etoposide—ABCG2—parotid gland—head and neck cancer	0.000164	0.01	CbGeAlD
Etoposide—GSTP1—thyroid gland—head and neck cancer	0.000164	0.01	CbGeAlD
Etoposide—ABCC10—thyroid gland—head and neck cancer	0.000164	0.01	CbGeAlD
Etoposide—Cardiac failure—Docetaxel—head and neck cancer	0.000163	0.00237	CcSEcCtD
Etoposide—TOP2B—lymph node—head and neck cancer	0.000162	0.00992	CbGeAlD
Etoposide—Thrombocytopenia—Vinblastine—head and neck cancer	0.000162	0.00235	CcSEcCtD
Etoposide—Convulsion—Hydroxyurea—head and neck cancer	0.00016	0.00233	CcSEcCtD
Etoposide—Agranulocytosis—Fluorouracil—head and neck cancer	0.000159	0.00231	CcSEcCtD
Etoposide—Anorexia—Vinblastine—head and neck cancer	0.000157	0.00229	CcSEcCtD
Etoposide—ABCG2—saliva-secreting gland—head and neck cancer	0.000157	0.0096	CbGeAlD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000156	0.00227	CcSEcCtD
Etoposide—Discomfort—Hydroxyurea—head and neck cancer	0.000155	0.00226	CcSEcCtD
Etoposide—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000152	0.00221	CcSEcCtD
Etoposide—Infection—Hydroxyurea—head and neck cancer	0.00015	0.00218	CcSEcCtD
Etoposide—Paraesthesia—Vinblastine—head and neck cancer	0.000148	0.00216	CcSEcCtD
Etoposide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000148	0.00214	CcSEcCtD
Etoposide—Skin disorder—Hydroxyurea—head and neck cancer	0.000146	0.00213	CcSEcCtD
Etoposide—ABCC1—trachea—head and neck cancer	0.000146	0.00894	CbGeAlD
Etoposide—ABCC3—head—head and neck cancer	0.000146	0.00892	CbGeAlD
Etoposide—GSTP1—head—head and neck cancer	0.000145	0.00888	CbGeAlD
Etoposide—Anorexia—Hydroxyurea—head and neck cancer	0.000144	0.00209	CcSEcCtD
Etoposide—Decreased appetite—Vinblastine—head and neck cancer	0.000144	0.00209	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000143	0.00209	CcSEcCtD
Etoposide—Cramp muscle—Docetaxel—head and neck cancer	0.000143	0.00209	CcSEcCtD
Etoposide—Pain—Vinblastine—head and neck cancer	0.000141	0.00205	CcSEcCtD
Etoposide—Constipation—Vinblastine—head and neck cancer	0.000141	0.00205	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00014	0.00204	CcSEcCtD
Etoposide—Dysphagia—Docetaxel—head and neck cancer	0.000138	0.002	CcSEcCtD
Etoposide—Feeling abnormal—Vinblastine—head and neck cancer	0.000136	0.00198	CcSEcCtD
Etoposide—Bronchospasm—Docetaxel—head and neck cancer	0.000135	0.00197	CcSEcCtD
Etoposide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000135	0.00196	CcSEcCtD
Etoposide—Alopecia—Fluorouracil—head and neck cancer	0.000135	0.00196	CcSEcCtD
Etoposide—Dyspnoea—Hydroxyurea—head and neck cancer	0.000134	0.00195	CcSEcCtD
Etoposide—Somnolence—Hydroxyurea—head and neck cancer	0.000134	0.00195	CcSEcCtD
Etoposide—Decreased appetite—Hydroxyurea—head and neck cancer	0.000131	0.0019	CcSEcCtD
Etoposide—Pancytopenia—Docetaxel—head and neck cancer	0.000131	0.0019	CcSEcCtD
Etoposide—Abdominal pain—Vinblastine—head and neck cancer	0.000131	0.0019	CcSEcCtD
Etoposide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00013	0.00189	CcSEcCtD
Etoposide—Fatigue—Hydroxyurea—head and neck cancer	0.00013	0.00189	CcSEcCtD
Etoposide—Constipation—Hydroxyurea—head and neck cancer	0.000129	0.00187	CcSEcCtD
Etoposide—Pain—Hydroxyurea—head and neck cancer	0.000129	0.00187	CcSEcCtD
Etoposide—Neutropenia—Docetaxel—head and neck cancer	0.000129	0.00187	CcSEcCtD
Etoposide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000124	0.00181	CcSEcCtD
Etoposide—Pneumonia—Docetaxel—head and neck cancer	0.000123	0.00179	CcSEcCtD
Etoposide—Anaemia—Fluorouracil—head and neck cancer	0.000123	0.00179	CcSEcCtD
Etoposide—Infestation NOS—Docetaxel—head and neck cancer	0.000123	0.00178	CcSEcCtD
Etoposide—Infestation—Docetaxel—head and neck cancer	0.000123	0.00178	CcSEcCtD
Etoposide—Hypersensitivity—Vinblastine—head and neck cancer	0.000122	0.00177	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000122	0.00177	CcSEcCtD
Etoposide—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000121	0.00176	CcSEcCtD
Etoposide—Renal failure—Docetaxel—head and neck cancer	0.000121	0.00175	CcSEcCtD
Etoposide—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00012	0.00175	CcSEcCtD
Etoposide—Myocardial infarction—Docetaxel—head and neck cancer	0.00012	0.00175	CcSEcCtD
Etoposide—PTGS1—connective tissue—head and neck cancer	0.00012	0.00735	CbGeAlD
Etoposide—Jaundice—Docetaxel—head and neck cancer	0.00012	0.00174	CcSEcCtD
Etoposide—Stomatitis—Docetaxel—head and neck cancer	0.00012	0.00174	CcSEcCtD
Etoposide—TOP2A—lymph node—head and neck cancer	0.000119	0.0073	CbGeAlD
Etoposide—Body temperature increased—Hydroxyurea—head and neck cancer	0.000119	0.00173	CcSEcCtD
Etoposide—Leukopenia—Fluorouracil—head and neck cancer	0.000119	0.00173	CcSEcCtD
Etoposide—Asthenia—Vinblastine—head and neck cancer	0.000119	0.00172	CcSEcCtD
Etoposide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000116	0.00169	CcSEcCtD
Etoposide—ABCC1—thyroid gland—head and neck cancer	0.000116	0.00707	CbGeAlD
Etoposide—Convulsion—Fluorouracil—head and neck cancer	0.000115	0.00167	CcSEcCtD
Etoposide—PTGS2—connective tissue—head and neck cancer	0.000115	0.00703	CbGeAlD
Etoposide—Agranulocytosis—Docetaxel—head and neck cancer	0.000115	0.00167	CcSEcCtD
Etoposide—PTGS1—epithelium—head and neck cancer	0.000114	0.00698	CbGeAlD
Etoposide—Chest pain—Fluorouracil—head and neck cancer	0.000113	0.00164	CcSEcCtD
Etoposide—Diarrhoea—Vinblastine—head and neck cancer	0.000113	0.00164	CcSEcCtD
Etoposide—Discomfort—Fluorouracil—head and neck cancer	0.000112	0.00163	CcSEcCtD
Etoposide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000111	0.00161	CcSEcCtD
Etoposide—Hypoaesthesia—Docetaxel—head and neck cancer	0.00011	0.00159	CcSEcCtD
Etoposide—Confusional state—Fluorouracil—head and neck cancer	0.000109	0.00159	CcSEcCtD
Etoposide—Dizziness—Vinblastine—head and neck cancer	0.000109	0.00159	CcSEcCtD
Etoposide—PTGS2—epithelium—head and neck cancer	0.000109	0.00667	CbGeAlD
Etoposide—Urinary tract disorder—Docetaxel—head and neck cancer	0.000109	0.00158	CcSEcCtD
Etoposide—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000108	0.00158	CcSEcCtD
Etoposide—Asthenia—Hydroxyurea—head and neck cancer	0.000108	0.00157	CcSEcCtD
Etoposide—Urethral disorder—Docetaxel—head and neck cancer	0.000108	0.00157	CcSEcCtD
Etoposide—Infection—Fluorouracil—head and neck cancer	0.000108	0.00157	CcSEcCtD
Etoposide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000106	0.00154	CcSEcCtD
Etoposide—Tachycardia—Fluorouracil—head and neck cancer	0.000106	0.00154	CcSEcCtD
Etoposide—Vomiting—Vinblastine—head and neck cancer	0.000105	0.00153	CcSEcCtD
Etoposide—Erythema multiforme—Docetaxel—head and neck cancer	0.000104	0.00151	CcSEcCtD
Etoposide—Headache—Vinblastine—head and neck cancer	0.000103	0.0015	CcSEcCtD
Etoposide—Anorexia—Fluorouracil—head and neck cancer	0.000103	0.0015	CcSEcCtD
Etoposide—Diarrhoea—Hydroxyurea—head and neck cancer	0.000103	0.0015	CcSEcCtD
Etoposide—Eye disorder—Docetaxel—head and neck cancer	0.000103	0.0015	CcSEcCtD
Etoposide—Cardiac disorder—Docetaxel—head and neck cancer	0.000102	0.00149	CcSEcCtD
Etoposide—Flushing—Docetaxel—head and neck cancer	0.000102	0.00149	CcSEcCtD
Etoposide—ABCC3—lymph node—head and neck cancer	0.000102	0.00624	CbGeAlD
Etoposide—GSTP1—lymph node—head and neck cancer	0.000102	0.00622	CbGeAlD
Etoposide—ABCC10—lymph node—head and neck cancer	0.000102	0.00621	CbGeAlD
Etoposide—Hypotension—Fluorouracil—head and neck cancer	0.000101	0.00147	CcSEcCtD
Etoposide—PTGS1—trachea—head and neck cancer	0.000101	0.00617	CbGeAlD
Etoposide—Angiopathy—Docetaxel—head and neck cancer	0.0001	0.00145	CcSEcCtD
Etoposide—Dizziness—Hydroxyurea—head and neck cancer	9.96e-05	0.00145	CcSEcCtD
Etoposide—Immune system disorder—Docetaxel—head and neck cancer	9.95e-05	0.00145	CcSEcCtD
Etoposide—Mediastinal disorder—Docetaxel—head and neck cancer	9.93e-05	0.00144	CcSEcCtD
Etoposide—Chills—Docetaxel—head and neck cancer	9.89e-05	0.00144	CcSEcCtD
Etoposide—Nausea—Vinblastine—head and neck cancer	9.81e-05	0.00143	CcSEcCtD
Etoposide—Paraesthesia—Fluorouracil—head and neck cancer	9.74e-05	0.00142	CcSEcCtD
Etoposide—Alopecia—Docetaxel—head and neck cancer	9.74e-05	0.00142	CcSEcCtD
Etoposide—Dyspnoea—Fluorouracil—head and neck cancer	9.67e-05	0.00141	CcSEcCtD
Etoposide—PTGS2—trachea—head and neck cancer	9.65e-05	0.0059	CbGeAlD
Etoposide—Somnolence—Fluorouracil—head and neck cancer	9.64e-05	0.0014	CcSEcCtD
Etoposide—Vomiting—Hydroxyurea—head and neck cancer	9.58e-05	0.00139	CcSEcCtD
Etoposide—ABCG2—thyroid gland—head and neck cancer	9.58e-05	0.00586	CbGeAlD
Etoposide—Rash—Hydroxyurea—head and neck cancer	9.5e-05	0.00138	CcSEcCtD
Etoposide—Dermatitis—Hydroxyurea—head and neck cancer	9.49e-05	0.00138	CcSEcCtD
Etoposide—Headache—Hydroxyurea—head and neck cancer	9.44e-05	0.00137	CcSEcCtD
Etoposide—Decreased appetite—Fluorouracil—head and neck cancer	9.43e-05	0.00137	CcSEcCtD
Etoposide—Dysgeusia—Docetaxel—head and neck cancer	9.39e-05	0.00137	CcSEcCtD
Etoposide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	9.36e-05	0.00136	CcSEcCtD
Etoposide—Back pain—Docetaxel—head and neck cancer	9.28e-05	0.00135	CcSEcCtD
Etoposide—Pain—Fluorouracil—head and neck cancer	9.27e-05	0.00135	CcSEcCtD
Etoposide—Muscle spasms—Docetaxel—head and neck cancer	9.22e-05	0.00134	CcSEcCtD
Etoposide—CYP1A2—thyroid gland—head and neck cancer	9.22e-05	0.00564	CbGeAlD
Etoposide—CYP2E1—lymphoid tissue—head and neck cancer	9.13e-05	0.00558	CbGeAlD
Etoposide—Nausea—Hydroxyurea—head and neck cancer	8.95e-05	0.0013	CcSEcCtD
Etoposide—Feeling abnormal—Fluorouracil—head and neck cancer	8.94e-05	0.0013	CcSEcCtD
Etoposide—Anaemia—Docetaxel—head and neck cancer	8.86e-05	0.00129	CcSEcCtD
Etoposide—Urticaria—Fluorouracil—head and neck cancer	8.62e-05	0.00125	CcSEcCtD
Etoposide—Leukopenia—Docetaxel—head and neck cancer	8.58e-05	0.00125	CcSEcCtD
Etoposide—Body temperature increased—Fluorouracil—head and neck cancer	8.57e-05	0.00125	CcSEcCtD
Etoposide—Loss of consciousness—Docetaxel—head and neck cancer	8.43e-05	0.00123	CcSEcCtD
Etoposide—PTGS2—lymphoid tissue—head and neck cancer	8.41e-05	0.00514	CbGeAlD
Etoposide—Cough—Docetaxel—head and neck cancer	8.37e-05	0.00122	CcSEcCtD
Etoposide—Convulsion—Docetaxel—head and neck cancer	8.31e-05	0.00121	CcSEcCtD
Etoposide—CYP2E1—thyroid gland—head and neck cancer	8.29e-05	0.00507	CbGeAlD
Etoposide—Hypertension—Docetaxel—head and neck cancer	8.28e-05	0.0012	CcSEcCtD
Etoposide—Chest pain—Docetaxel—head and neck cancer	8.17e-05	0.00119	CcSEcCtD
Etoposide—ABCC2—lymph node—head and neck cancer	8.16e-05	0.00499	CbGeAlD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	8.11e-05	0.00118	CcSEcCtD
Etoposide—Hypersensitivity—Fluorouracil—head and neck cancer	7.99e-05	0.00116	CcSEcCtD
Etoposide—PTGS1—thyroid gland—head and neck cancer	7.99e-05	0.00488	CbGeAlD
Etoposide—Confusional state—Docetaxel—head and neck cancer	7.89e-05	0.00115	CcSEcCtD
Etoposide—Anaphylactic shock—Docetaxel—head and neck cancer	7.83e-05	0.00114	CcSEcCtD
Etoposide—Infection—Docetaxel—head and neck cancer	7.78e-05	0.00113	CcSEcCtD
Etoposide—Pruritus—Fluorouracil—head and neck cancer	7.67e-05	0.00112	CcSEcCtD
Etoposide—Thrombocytopenia—Docetaxel—head and neck cancer	7.66e-05	0.00111	CcSEcCtD
Etoposide—Tachycardia—Docetaxel—head and neck cancer	7.64e-05	0.00111	CcSEcCtD
Etoposide—Skin disorder—Docetaxel—head and neck cancer	7.6e-05	0.00111	CcSEcCtD
Etoposide—Anorexia—Docetaxel—head and neck cancer	7.46e-05	0.00108	CcSEcCtD
Etoposide—Diarrhoea—Fluorouracil—head and neck cancer	7.42e-05	0.00108	CcSEcCtD
Etoposide—CYP2E1—head—head and neck cancer	7.36e-05	0.0045	CbGeAlD
Etoposide—Hypotension—Docetaxel—head and neck cancer	7.31e-05	0.00106	CcSEcCtD
Etoposide—ABCC1—lymph node—head and neck cancer	7.19e-05	0.00439	CbGeAlD
Etoposide—Dizziness—Fluorouracil—head and neck cancer	7.17e-05	0.00104	CcSEcCtD
Etoposide—PTGS1—head—head and neck cancer	7.09e-05	0.00433	CbGeAlD
Etoposide—Paraesthesia—Docetaxel—head and neck cancer	7.03e-05	0.00102	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—head and neck cancer	6.98e-05	0.00101	CcSEcCtD
Etoposide—Somnolence—Docetaxel—head and neck cancer	6.96e-05	0.00101	CcSEcCtD
Etoposide—Vomiting—Fluorouracil—head and neck cancer	6.9e-05	0.001	CcSEcCtD
Etoposide—Rash—Fluorouracil—head and neck cancer	6.84e-05	0.000994	CcSEcCtD
Etoposide—Dermatitis—Fluorouracil—head and neck cancer	6.83e-05	0.000993	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—head and neck cancer	6.8e-05	0.000989	CcSEcCtD
Etoposide—Headache—Fluorouracil—head and neck cancer	6.79e-05	0.000988	CcSEcCtD
Etoposide—PTGS2—head—head and neck cancer	6.77e-05	0.00414	CbGeAlD
Etoposide—Gastrointestinal disorder—Docetaxel—head and neck cancer	6.76e-05	0.000983	CcSEcCtD
Etoposide—ABCB1—epithelium—head and neck cancer	6.75e-05	0.00413	CbGeAlD
Etoposide—Fatigue—Docetaxel—head and neck cancer	6.75e-05	0.000981	CcSEcCtD
Etoposide—Pain—Docetaxel—head and neck cancer	6.69e-05	0.000973	CcSEcCtD
Etoposide—Constipation—Docetaxel—head and neck cancer	6.69e-05	0.000973	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—head and neck cancer	6.45e-05	0.000938	CcSEcCtD
Etoposide—Nausea—Fluorouracil—head and neck cancer	6.44e-05	0.000937	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—head and neck cancer	6.4e-05	0.000931	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—head and neck cancer	6.19e-05	0.0009	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—head and neck cancer	6.19e-05	0.0009	CcSEcCtD
Etoposide—ABCB1—trachea—head and neck cancer	5.97e-05	0.00365	CbGeAlD
Etoposide—ABCG2—lymph node—head and neck cancer	5.95e-05	0.00364	CbGeAlD
Etoposide—Hypersensitivity—Docetaxel—head and neck cancer	5.77e-05	0.000839	CcSEcCtD
Etoposide—Asthenia—Docetaxel—head and neck cancer	5.62e-05	0.000817	CcSEcCtD
Etoposide—Pruritus—Docetaxel—head and neck cancer	5.54e-05	0.000805	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—head and neck cancer	5.36e-05	0.000779	CcSEcCtD
Etoposide—ABCB1—lymphoid tissue—head and neck cancer	5.2e-05	0.00318	CbGeAlD
Etoposide—Dizziness—Docetaxel—head and neck cancer	5.18e-05	0.000753	CcSEcCtD
Etoposide—Vomiting—Docetaxel—head and neck cancer	4.98e-05	0.000724	CcSEcCtD
Etoposide—PTGS1—lymph node—head and neck cancer	4.96e-05	0.00303	CbGeAlD
Etoposide—Rash—Docetaxel—head and neck cancer	4.94e-05	0.000718	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—head and neck cancer	4.93e-05	0.000717	CcSEcCtD
Etoposide—Headache—Docetaxel—head and neck cancer	4.9e-05	0.000713	CcSEcCtD
Etoposide—PTGS2—lymph node—head and neck cancer	4.74e-05	0.0029	CbGeAlD
Etoposide—ABCB1—thyroid gland—head and neck cancer	4.72e-05	0.00289	CbGeAlD
Etoposide—Nausea—Docetaxel—head and neck cancer	4.65e-05	0.000676	CcSEcCtD
Etoposide—ABCB1—head—head and neck cancer	4.19e-05	0.00256	CbGeAlD
Etoposide—ABCB1—lymph node—head and neck cancer	2.93e-05	0.00179	CbGeAlD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	1.95e-05	0.000683	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.91e-05	0.00067	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.9e-05	0.000669	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.89e-05	0.000665	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—NAT2—head and neck cancer	1.89e-05	0.000664	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	1.87e-05	0.000655	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	1.87e-05	0.000655	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	1.87e-05	0.000655	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.86e-05	0.000652	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	1.83e-05	0.000643	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.83e-05	0.000641	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—UROD—head and neck cancer	1.7e-05	0.000596	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.68e-05	0.000592	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—DPYD—head and neck cancer	1.66e-05	0.000582	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	1.64e-05	0.000574	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	1.63e-05	0.000573	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	1.63e-05	0.000571	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.61e-05	0.000566	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	1.6e-05	0.000563	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.57e-05	0.000553	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—YAP1—head and neck cancer	1.57e-05	0.000553	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.57e-05	0.00055	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.56e-05	0.000547	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTGS2—head and neck cancer	1.56e-05	0.000546	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	1.55e-05	0.000545	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	1.55e-05	0.000545	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	1.54e-05	0.000541	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NAT2—head and neck cancer	1.54e-05	0.00054	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—TYMS—head and neck cancer	1.53e-05	0.000537	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	1.52e-05	0.000534	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.51e-05	0.000531	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GSTM1—head and neck cancer	1.51e-05	0.000531	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	1.5e-05	0.000526	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NAT2—head and neck cancer	1.48e-05	0.00052	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GPX1—head and neck cancer	1.45e-05	0.000508	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CYP1A1—head and neck cancer	1.43e-05	0.000503	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.4e-05	0.000492	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTEN—head and neck cancer	1.36e-05	0.000476	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—UROD—head and neck cancer	1.36e-05	0.000476	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—DPYD—head and neck cancer	1.35e-05	0.000473	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.35e-05	0.000472	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.33e-05	0.000467	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.32e-05	0.000462	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NAT2—head and neck cancer	1.3e-05	0.000458	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	1.3e-05	0.000457	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—DPYD—head and neck cancer	1.3e-05	0.000456	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.3e-05	0.000456	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.29e-05	0.000455	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—YAP1—head and neck cancer	1.28e-05	0.000449	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.25e-05	0.00044	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND1—head and neck cancer	1.25e-05	0.00044	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NAT2—head and neck cancer	1.25e-05	0.00044	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.24e-05	0.000436	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.24e-05	0.000434	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—YAP1—head and neck cancer	1.23e-05	0.000433	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.19e-05	0.000418	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.18e-05	0.000415	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.17e-05	0.000412	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.17e-05	0.000412	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.16e-05	0.000406	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—DPYD—head and neck cancer	1.14e-05	0.000401	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.11e-05	0.00039	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.11e-05	0.00039	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.1e-05	0.000386	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—DPYD—head and neck cancer	1.1e-05	0.000386	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—YAP1—head and neck cancer	1.09e-05	0.000381	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.06e-05	0.000371	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.06e-05	0.000371	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.06e-05	0.000371	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.06e-05	0.000371	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.05e-05	0.000369	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—UROD—head and neck cancer	1.05e-05	0.000367	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.05e-05	0.000367	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—YAP1—head and neck cancer	1.04e-05	0.000366	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MAPK3—head and neck cancer	1.03e-05	0.000363	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.03e-05	0.000362	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NAT2—head and neck cancer	9.95e-06	0.000349	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MAPK1—head and neck cancer	9.84e-06	0.000345	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PIK3CA—head and neck cancer	9.57e-06	0.000336	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.54e-06	0.000335	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—TYMS—head and neck cancer	9.45e-06	0.000332	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NAT2—head and neck cancer	9.36e-06	0.000329	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NAT2—head and neck cancer	9.34e-06	0.000328	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSTM1—head and neck cancer	9.34e-06	0.000328	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.27e-06	0.000325	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	9.21e-06	0.000323	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.16e-06	0.000322	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GPX1—head and neck cancer	8.95e-06	0.000314	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8.86e-06	0.000311	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CYP1A1—head and neck cancer	8.86e-06	0.000311	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—DPYD—head and neck cancer	8.72e-06	0.000306	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.59e-06	0.000302	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTGS2—head and neck cancer	8.52e-06	0.000299	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.51e-06	0.000299	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	8.32e-06	0.000292	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—YAP1—head and neck cancer	8.28e-06	0.000291	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—head and neck cancer	8.26e-06	0.00029	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—DPYD—head and neck cancer	8.21e-06	0.000288	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—DPYD—head and neck cancer	8.19e-06	0.000288	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NAT2—head and neck cancer	8.09e-06	0.000284	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.08e-06	0.000284	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.87e-06	0.000276	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.83e-06	0.000275	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—head and neck cancer	7.82e-06	0.000275	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—YAP1—head and neck cancer	7.79e-06	0.000274	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—YAP1—head and neck cancer	7.77e-06	0.000273	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—TYMS—head and neck cancer	7.68e-06	0.00027	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTM1—head and neck cancer	7.59e-06	0.000267	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.48e-06	0.000263	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.48e-06	0.000263	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.48e-06	0.000263	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTEN—head and neck cancer	7.43e-06	0.000261	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—TYMS—head and neck cancer	7.4e-06	0.00026	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTM1—head and neck cancer	7.32e-06	0.000257	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.28e-06	0.000255	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GPX1—head and neck cancer	7.27e-06	0.000255	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP1A1—head and neck cancer	7.2e-06	0.000253	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—DPYD—head and neck cancer	7.1e-06	0.000249	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NAT2—head and neck cancer	7.05e-06	0.000248	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GPX1—head and neck cancer	7.01e-06	0.000246	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP1A1—head and neck cancer	6.94e-06	0.000244	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.83e-06	0.00024	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—YAP1—head and neck cancer	6.73e-06	0.000236	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOTCH1—head and neck cancer	6.64e-06	0.000233	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TYMS—head and neck cancer	6.52e-06	0.000229	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.49e-06	0.000228	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTM1—head and neck cancer	6.44e-06	0.000226	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.28e-06	0.000221	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TYMS—head and neck cancer	6.26e-06	0.00022	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTM1—head and neck cancer	6.19e-06	0.000217	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—DPYD—head and neck cancer	6.18e-06	0.000217	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GPX1—head and neck cancer	6.17e-06	0.000217	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1A1—head and neck cancer	6.11e-06	0.000214	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.98e-06	0.00021	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GPX1—head and neck cancer	5.93e-06	0.000208	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.92e-06	0.000208	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—YAP1—head and neck cancer	5.87e-06	0.000206	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1A1—head and neck cancer	5.87e-06	0.000206	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.7e-06	0.0002	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NAT2—head and neck cancer	5.63e-06	0.000198	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.42e-06	0.00019	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.31e-06	0.000186	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—head and neck cancer	5.27e-06	0.000185	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—head and neck cancer	5.24e-06	0.000184	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.06e-06	0.000178	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TYMS—head and neck cancer	4.97e-06	0.000174	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—DPYD—head and neck cancer	4.94e-06	0.000173	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—head and neck cancer	4.93e-06	0.000173	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTM1—head and neck cancer	4.91e-06	0.000172	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.82e-06	0.000169	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GPX1—head and neck cancer	4.7e-06	0.000165	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—YAP1—head and neck cancer	4.68e-06	0.000164	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TYMS—head and neck cancer	4.68e-06	0.000164	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TYMS—head and neck cancer	4.67e-06	0.000164	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1A1—head and neck cancer	4.66e-06	0.000163	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—head and neck cancer	4.62e-06	0.000162	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—head and neck cancer	4.61e-06	0.000162	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—head and neck cancer	4.59e-06	0.000161	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOTCH1—head and neck cancer	4.45e-06	0.000156	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GPX1—head and neck cancer	4.43e-06	0.000155	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GPX1—head and neck cancer	4.42e-06	0.000155	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.41e-06	0.000155	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1A1—head and neck cancer	4.38e-06	0.000154	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1A1—head and neck cancer	4.37e-06	0.000154	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NAT2—head and neck cancer	4.34e-06	0.000153	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—head and neck cancer	4.3e-06	0.000151	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—head and neck cancer	4.28e-06	0.00015	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—head and neck cancer	4.28e-06	0.00015	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—head and neck cancer	4.13e-06	0.000145	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TYMS—head and neck cancer	4.04e-06	0.000142	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—head and neck cancer	4e-06	0.00014	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—head and neck cancer	3.84e-06	0.000135	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GPX1—head and neck cancer	3.83e-06	0.000134	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.83e-06	0.000134	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—DPYD—head and neck cancer	3.81e-06	0.000134	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3.79e-06	0.000133	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—head and neck cancer	3.73e-06	0.000131	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—head and neck cancer	3.67e-06	0.000129	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—head and neck cancer	3.63e-06	0.000127	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—YAP1—head and neck cancer	3.61e-06	0.000127	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—head and neck cancer	3.6e-06	0.000126	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMS—head and neck cancer	3.52e-06	0.000124	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.52e-06	0.000124	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK1—head and neck cancer	3.49e-06	0.000123	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—head and neck cancer	3.49e-06	0.000123	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—head and neck cancer	3.49e-06	0.000122	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—head and neck cancer	3.48e-06	0.000122	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GPX1—head and neck cancer	3.33e-06	0.000117	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.3e-06	0.000116	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—head and neck cancer	3.24e-06	0.000114	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—head and neck cancer	3.17e-06	0.000111	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.11e-06	0.000109	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.07e-06	0.000108	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—head and neck cancer	3.04e-06	0.000107	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—head and neck cancer	3.03e-06	0.000106	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—head and neck cancer	2.88e-06	0.000101	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMS—head and neck cancer	2.81e-06	9.87e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—head and neck cancer	2.8e-06	9.85e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.78e-06	9.76e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPX1—head and neck cancer	2.66e-06	9.35e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—head and neck cancer	2.65e-06	9.29e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.64e-06	9.25e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—head and neck cancer	2.63e-06	9.24e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—head and neck cancer	2.61e-06	9.15e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.6e-06	9.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—head and neck cancer	2.58e-06	9.06e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—head and neck cancer	2.54e-06	8.91e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—head and neck cancer	2.48e-06	8.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—head and neck cancer	2.46e-06	8.65e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—head and neck cancer	2.42e-06	8.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK1—head and neck cancer	2.34e-06	8.23e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—head and neck cancer	2.34e-06	8.23e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—head and neck cancer	2.27e-06	7.98e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—head and neck cancer	2.27e-06	7.97e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.25e-06	7.91e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—head and neck cancer	2.23e-06	7.84e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMS—head and neck cancer	2.17e-06	7.62e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.16e-06	7.6e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—head and neck cancer	2.15e-06	7.55e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—head and neck cancer	2.15e-06	7.54e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.15e-06	7.53e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—head and neck cancer	2.07e-06	7.28e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPX1—head and neck cancer	2.05e-06	7.21e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—head and neck cancer	2.03e-06	7.14e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.03e-06	7.14e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—head and neck cancer	1.97e-06	6.9e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—head and neck cancer	1.96e-06	6.89e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—head and neck cancer	1.88e-06	6.61e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—head and neck cancer	1.82e-06	6.41e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—head and neck cancer	1.75e-06	6.16e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—head and neck cancer	1.71e-06	6.01e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.7e-06	5.98e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—head and neck cancer	1.66e-06	5.84e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.6e-06	5.63e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.6e-06	5.62e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.57e-06	5.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—head and neck cancer	1.39e-06	4.89e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.39e-06	4.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—head and neck cancer	1.37e-06	4.8e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—head and neck cancer	1.31e-06	4.6e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—head and neck cancer	1.31e-06	4.59e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.21e-06	4.25e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.21e-06	4.24e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—head and neck cancer	1.13e-06	3.98e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—head and neck cancer	1.05e-06	3.7e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—head and neck cancer	9.87e-07	3.46e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—head and neck cancer	9.64e-07	3.39e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—head and neck cancer	7.88e-07	2.77e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.44e-07	2.61e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—head and neck cancer	6.08e-07	2.13e-05	CbGpPWpGaD
